Needham & Company reiterates their Buy rating on Imperva, Inc. (NYSE: IMPV), and raised the price target to $67 (from ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE